Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Type of study
Language
Year range
1.
JCPSP-Journal of the College of Physicians and Surgeons Pakistan. 2005; 15 (8): 502-504
in English | IMEMR | ID: emr-71626

ABSTRACT

This case report describes the occurrence of carcinoma in gastric stump in a man who underwent partial gastrectomy with anastomosis 20 years back for duodenal ulcer. Surgical resection and anastomosis was followed by adjuvant chemotherapy


Subject(s)
Humans , Male , Stomach Neoplasms/surgery , Stomach Neoplasms/complications , Gastrectomy , Duodenal Ulcer , Anastomosis, Surgical , Drug Therapy , Duodenogastric Reflux , Carcinogens , Gastric Juice , Lymph Node Excision
2.
PAFMJ-Pakistan Armed Forces Medical Journal. 2005; 55 (2): 146-155
in English | IMEMR | ID: emr-173014

ABSTRACT

Pancreatic cancer is highly lethal disease that is rising in incidence. Chemotherapy based on 5-fluorouracil [5-FU] has shown to prolong survival in advanced pancreatic cancer modestly. Gemcitabine improves major symptoms and survival outcomes compared with 5-FU. Many compounds have been investigated. These compounds are based on classical mechanisms of action as well as biological therapies targeting cellular pathways, and include fluoropyrimidines, nucleoside cytidine analogues, platinum analogues, topoisomerase inhibitors, antimicrotubule agents, proteasome inhibitors, vitamin D analogues, arachidonic acid pathway inhibitors, histone deacytylator inhibitors, farnesyltransferase inhibitors, epidermal growth factor receptor therapies and many more. Out of these some have shown their promise. Many more compounds are being tested and real advances are anticipated in the near future

SELECTION OF CITATIONS
SEARCH DETAIL